Posted by Michael Wonder on 19 Nov 2018
Innovative skin cancer drug available on Cancer Drugs Fund
19 November 2018 - Patients with a type of advanced skin cancer have a new treatment option as pembrolizumab, also known as Keytruda, has been recommended for use on the Cancer Drugs Fund.
This recommendation applies to adults who have melanoma that has spread to the lymph nodes, an important part of the body’s natural defence system.
Pembrolizumab would be offered to patients who have already had surgery to remove the cancer. Called an adjuvant immunotherapy, it aims to remove any cancer left behind.
